Mylan is the largest manufacturer of HIV Aids medicine in the world, treating around 40%  of people with the disease

Global generic drugmaker Mylan will this week launch a HIV self-test kit in the Irish market in the first intervention of its kind to aid early detect(...)

Face value: Novum has raised the price of a 60g tube of Aloquin, which is used to treat conditions such as eczema and acne, by 128 per cent to $9,561. Photograph: iStockphoto

A US drugmaker producing skin creams for common conditions such as acne and eczema has raised the price of two of its treatments to almost $10,000 a (...)

Epinephrine is used as an emergency treatment for an acute allergic reaction.  Photograph: iStock

Mylan said it would take immediate action to cut the cost of its EpiPen emergency allergy shot following pressure from politicians including US presid(...)

 Robert Coury, executive chairman of  Mylan pharmacutical company with Taoiseach Enda Kenny in 2012 announcing more than 500 jobs between plants at Baldoyle in Dublin and Galway.Photograph: Alan Betson / The Irish Times

Drugmaker Mylan posted a 17 per cent rise in quarterly revenue, helped by higher generic drug sales, and stood by its full-year revenue and adjusted p(...)

Privately, some shareholders have been scathing about the tactics Mylan used to defend itself from a hostile takeover  by Teva. Photograph: Getty Images

Mylan, the generic drugs group, has launched a staunch defence of the tactics it used to repel a $40 billion hostile takeover attempt by Teva, amid po(...)

Joe Papa, CEO and president of Perrigo

The ripple effect of the wave of corporate inversion in the pharma/medtech sector continues to drive the ongoing wave of consolidation.Less than two y(...)

A generic form of the drug Plavix sits on crates at a Mylan Pharmaceuticals distribution centre in North Carolina.  Mylan has offered to acquire Perrigo for about $29 billion in what would be the latest mega-merger among drug makers if it is completed. Photograph: Travis Dove/The New York Times

Drugmaker Mylan offered to buy rival Perrigo for $28.9 billion in a deal that would create a powerhouse for generic medicine. Mylan, which makes abo(...)